Revisiting the utility of TDP-43 immunoreactive (TDP-43-ir) pathology to classify FTLD-TDP subtypes

Acta Neuropathol. 2019 Jul;138(1):167-169. doi: 10.1007/s00401-019-02024-w. Epub 2019 May 7.

Yasushi Nishihira¹, Tamar Gefen^{2

3}, Qinwen Mao^{1

3}, Christina Appin¹, Missia Kohler¹, Jamie Walker¹, Rosa Rademakers⁴, Alfred Rademaker^{3

5}, Emily Rogalski^{2

3}, Sandra Weintraub^{2

3}, Changiz Geula³, M-Marsel Mesulam^{3

6}, Eileen H Bigio^{7

8}

¹ Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
² Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
³ Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
⁴ Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
⁵ Department of Preventative Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
⁶ Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
⁷ Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. e-bigio@northwestern.edu.
⁸ Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. e-bigio@northwestern.edu.

No abstract available

Publication types